Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche

Showing 15 posts of 710 posts found.

Avastin

Roche gains new licence for blockbuster oncology drug

August 6, 2014
Research and Development, Sales and Marketing EC, Roche, avastin, ovarian cancer

Roche’s blockbuster cancer treatment Avastin now has a new European licence to treat women with a certain type of ovarian …

News
MabThera Roche

Blood cancer injection given green light

August 5, 2014
Research and Development, Sales and Marketing MabThera, Roche, follicular lymphoma and small lymphocytic lymphoma

Roche has launched a new injection formulation of its blood cancer drug MabThera (rituximab) to treat patients with follicular lymphoma, …

News

Gene silencing back on the books for Roche

August 5, 2014
Research and Development, Sales and Marketing RNA, Roche, Santaris, gene silencing

Roche will pay $450 million to acquire the RNA specialist firm Santaris Pharma in order to once again begin research …

News
Roche

Roche’s blood cancer drug gains EU approval

July 29, 2014
Research and Development, Sales and Marketing CLL, Cancer, Gilead, Janssen, Roche

The European Commission has approved Roche’s new leukaemia drug Gazyvaro (obinutuzumab) as competition for the blood cancer market heats up. …

News

GSK melanoma drugs beat rival in new study

July 18, 2014
Sales and Marketing GSK, Roche, Tafinlar, Yervoy, Zelboraf, mekinist, melanoma

GlaxoSmithKline’s new combination melanoma treatment has bested Roche’s established oncology drug Zelboraf when treating patients with the deadliest form of …

News
roche_logo_shadow_7

FDA speedy review for new Avastin licence

July 16, 2014
Research and Development, Sales and Marketing Cancer, Roche, avastin, cervical cancer

The FDA has granted priority review status for Roche’s Avastin (bevacizumab) plus chemotherapy in women with persistent, recurrent or metastatic …

News
roche_logo_shadow_7

Roche combination drug for melanoma impresses

July 14, 2014
Research and Development, Sales and Marketing GSK, Roche, Yervoy, braf, mekinist. MEK, melanoma

Roche’s investigational melanoma drug cobimetinib has helped late-stage patients live longer when used in combination with its established skin cancer …

News
Roche image

Roche lung cancer drug sees first approval

July 4, 2014
Sales and Marketing ALK+, Cancer, NSCLC, Pfizer, Roche, Xalkori, alectinib, alk, zykadia

Roche has seen the first approval for its new lung cancer drug alectinib in Japan as it looks to compete …

News

France ‘to approve’ Avastin use

July 3, 2014
Sales and Marketing AMD, France, Lucentis, Novartis, Roche, avastin, off label, off-label, wet AMD

The French government is planning to allow Roche’s cancer drug Avastin to be prescribed off-label to treat wet age-related macular …

News
Genentech image

Genentech to buy Seragon

July 3, 2014
Sales and Marketing Genentech, Roche, breast cancer, oncology, serds

Roche subsidiary Genentech is to pay around $1.7 billion for biotech firm Seragon Pharmaceuticals to secure its portfolio of potential …

News
Roche image

Roche to launch new MS collaboration

June 23, 2014
Research and Development, Sales and Marketing MS, Roche, inception sciences, multiple sclerosis, versant ventures

Roche has launched a new research collaboration to investigate ways of reversing the debilitating nerve damage caused by multiple sclerosis …

News

Italy eyes €1.2 billion pharma fine

May 30, 2014
Sales and Marketing Novartis, Roche, avastin, off label, wet and

Italy’s health ministry says it is looking for €1.2 billion in damages from Roche and Novartis over claims that the …

News
2_chrisroche-2

IT director Chris Roche joins Aridhia

May 30, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMC, IT, Roche, aridhia

Health tech informatics firm Aridhia has appointed Chris Roche to a newly-created post on its executive team as chief commercial …

Appointment
BMS image

BMS signs cancer deal

May 28, 2014
Research and Development, Sales and Marketing ASCO, AstraZeneca, BMS, Cancer, Merck, Roche, cytomx, oncology

Bristol-Myers Squibb has partnered with CytomX Therapeutics to discover and develop new immuno-oncology candidates using the latter’s Probody Platform technology. …

News
biogen_austria_238

Biogen gets CHMP thumbs up

May 27, 2014
Sales and Marketing Biogen, CHMP, Gazyvaro (obinutuzumab), Nuwiq, Octapharma, Orphan, Roche, chronic lymphocytic leukaemia, plegridy

Biogen Idec is celebrating after the Committee for Medicinal Products for Human Use (CHMP) gave its multiple sclerosis drug Plegridy …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025